Zhengye Biotechnology

Zhengye Biotechnology

Pharmaceuticals
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry, and other vaccines.

$58.8M

Market Cap • 10/2/2026

2023

(3 years)

Founded

2025

(1 year ago)

IPO

NASDAQ

Listing Exchange

Flag of China

China

Country

Valuation

P/B

1,6

P/S

3,5

P/EBITDA

—

P/OCF

30,8

P/FCF

33,4

P/E

—

BVPS

0,8

EPS

—

Market Cap

Market Cap

58,8M

EV

70,2M

EV/Revenue

4,2

EV/EBITDA

-11

EV/EBIT

-7

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-10,8%

Total Yield

-10,8%

Dividend Yield 5Y

0%

Payout

0%

Retained Earnings

-3,1M

Profitability

Gross Margin

20,5%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

15,5%

Capex/Revenue

0,9%

Capex/D&A

3,9%

Capex/OCF

7,6%

SBC/OCF

—

% PPE

54,4%

% Goodwill

0%

ROE

—

ROIC

—

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

1,1

Quick Ratio

0,6

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium